After a visit to Dana-Farber Cancer Institute in Boston earlier this month and some additional reserch, my UNC oncologist and I now have a treatment plan, with contingencies. It looks like a Imatinib Mesylate (Gleevec) clinical trial at Boston or Chapel Hill, if my tumor shows a KIT mutation; if not, a Temodar + ABT-888 trial in Charlotte, NC, or Temodar (temozolomide) alone at UNC. If that doesn't work and there is a lesion on or just below the skin, a Biovex trial. No skin lesion, an Avastin + Ipilimumab trial.
I stuck this post in here between blogging about new treatment options, so you can see that at least one person may be benefitting from the availability of research and clinical trials for melanoma and gets to feel good about contributing to the knowledge base.
Keep smilin'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment